Multifunctional nanomicellar systems for delivering anticancer drugs

Author:

Chen Yi-Chun12,Lo Chun-Liang3,Hsiue Ging-Ho12

Affiliation:

1. Department of Chemical Engineering; National Tsing Hua University; Hsinchu 300 Taiwan ROC

2. Department of Chemical Engineering and R&D Center for Membrane Technology; Chung Yuan Christian University; Chungli 320 Taiwan ROC

3. Department of Biomedical Engineering; National Yang Ming University; Taipei 112 Taiwan ROC

Funder

Department of Health of the Republic of China, Taiwan with National Research Program for Biopharmaceuticals

National Science Council of the Republic of China

Publisher

Wiley

Subject

Metals and Alloys,Biomedical Engineering,Biomaterials,Ceramics and Composites

Reference126 articles.

1. Erythropoietin improves myocardial performance in doxorubicin-induced cardiomyopathy;Hamed;Eur Heart J,2006

2. Doxorubicin induces apoptosis in normal and tumor cells via distinctly different mechanisms;Wang;J Biol Chem,2004

3. Influence of vesicle Size, lipid composition, and drug-to-lipid ratio on the biological activity of liposomal doxorubicin in mice;Mayer;Cancer Res,1989

4. Nanoparticle therapeutics: An emerging treatment modality for cancer;Davis;Nat Rev Drug Discov,2008

5. Multifunctional nanocarriers;Torchilin;Adv Drug Deliv Rev,2006

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3